(PharmaNewsWire.Com, August 14, 2017 ) According to Publisher, the Global Polymerase Chain Reaction market is accounted for $6.95 billion in 2015 and is expected to reach $12.56 billion by 2022 growing at a CAGR of 8.8% during the forecast period. Increasing investments in gene therapy and government support in R&D are some of the factors fueling the market growth. However, rising non-validated home brew test and reimbursement issues are hampering the market. Real time polymerase chain reaction instrument is one of the major challenges for the polymerase chain reaction technologies market.
Academics and research organizations hold the largest share in end users segment. Clinical diagnostic labs and hospitals market is anticipated to grow at a faster pace during the forecast period. North America is the leading PCR market followed by Europe, owing to rising demand for low-cost diagnosis in healthcare.
Some of the key players in Polymerase Chain Reaction market are Sigma-Aldrich Co. LLC., Thermo Fisher Scientific Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., Becton, Dickinson & Company, QIAGEN, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Beckman Coulter Inc., Affymetrix Inc., Abbott Laboratories, Cytocell Ltd, Shimadzu Biotech, HY LABORATORIES, Eppendorf AG, Exiqon, Dna Landmarks, Roche Diagnostics, Ocimum Biosolutions, BD Biosciences, Illumina, Complete Genomics, Dnavision SA, EpicentreĀ® Biotechnologies and Hokkaido System Science Co.
Products Covered: -Reagents and Consumables -Buffers -Consumable -Nuclease Free Water -Enzymes -Template -Primers And Probes -DNA -Master Mixes -dNTP's -Others Reagents and Consumables -Instruments -Digital PCR Systems -Standard PCR Systems -Digital PCR Systems
End Users Covered: -Academic and Research Organizations -Pharmaceutical and Biotechnology Industries -Clinical Diagnostics Labs and Hospitals -Other End Users -Blood Banks
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
1 Executive Summary 2 Preface 3 Market Trend Analysis 4 Porters Five Force Analysis 5 Global Polymerase Chain Reaction (PCR) Technologies Market, By Product 6 Global Polymerase Chain Reaction (PCR) Technologies Market, By Application 7 Global Polymerase Chain Reaction (PCR) Technologies Market, By Technology 8 Global Polymerase Chain Reaction (PCR) Technologies Market, By End User 9 Global Polymerase Chain Reaction (PCR) Technologies Market, By Geography 10 Key Developments
11 Company Profiling 11.1 Sigma-Aldrich Co. LLC. 11.2 Thermo Fisher Scientific, Inc. 11.3 GE Healthcare 11.4 F. Hoffmann-La Roche Ltd. 11.5 Becton, Dickinson & Company 11.6 QIAGEN 11.7 Agilent Technologies, Inc. 11.8 Bio-Rad Laboratories, Inc. 11.9 Beckman Coulter, Inc 11.10 Affymetrix, Inc. 11.11 Abbott Laboratories 11.12 Cytocell Ltd 11.13 Shimadzu Biotech 11.14 HY LABORATORIES 11.15 Eppendorf AG 11.16 Exiqon 11.17 Dna Landmarks 11.18 Roche Diagnostics 11.19 Ocimum Biosolutions 11.20 BD Biosciences 11.21 Illumina 11.22 Complete Genomics 11.23 Dnavision SA 11.24 EpicentreĀ® Biotechnologies 11.25 Hokkaido System Science Co.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
